Pages that link to "Q28390126"

The following pages link to Implementation of alternative test strategies for the safety assessment of engineered nanomaterials (Q28390126):

Displaying 34 items.

• Genotoxicity and carcinogenic potential of carbon nanomaterials (Q26322763) (← links)
• Biological Responses to Engineered Nanomaterials: Needs for the Next Decade (Q26750900) (← links)
• An ISA-TAB-Nano based data collection framework to support data-driven modelling of nanotoxicology (Q27942681) (← links)
• Emerging metrology for high-throughput nanomaterial genotoxicology (Q28078427) (← links)
• Activation of Proinflammatory Responses in Cells of the Airway Mucosa by Particulate Matter: Oxidant- and Non-Oxidant-Mediated Triggering Mechanisms (Q28390698) (← links)
• Comprehensive In Vitro Toxicity Testing of a Panel of Representative Oxide Nanomaterials: First Steps towards an Intelligent Testing Strategy (Q28394673) (← links)
• Mechanism-based genotoxicity screening of metal oxide nanoparticles using the ToxTracker panel of reporter cell lines (Q28397895) (← links)
• Cancer Biology, Toxicology and Alternative Methods Development Go Hand-in-Hand (Q28549191) (← links)
• 'Bio-nano interactions: new tools, insights and impacts': summary of the Royal Society discussion meeting. (Q30386039) (← links)
• Detection of Endotoxin Contamination of Graphene Based Materials Using the TNF-α Expression Test and Guidelines for Endotoxin-Free Graphene Oxide Production (Q36202649) (← links)
• Multilaboratory evaluation of 15 bioassays for (eco)toxicity screening and hazard ranking of engineered nanomaterials: FP7 project NANOVALID (Q37271603) (← links)
• Difficulties in establishing regulations for engineered nanomaterials and considerations for policy makers: avoiding an unbalance between benefits and risks. (Q38517151) (← links)
• Pro-Inflammatory and Pro-Fibrogenic Effects of Ionic and Particulate Arsenide and Indium-Containing Semiconductor Materials in the Murine Lung. (Q38972238) (← links)
• Systems Biology to Support Nanomaterial Grouping (Q38974885) (← links)
• Cell-based cytotoxicity assays for engineered nanomaterials safety screening: exposure of adipose derived stromal cells to titanium dioxide nanoparticles (Q40978874) (← links)
• Improved methods for evaluating the environmental impact of nanoparticle synthesis†. (Q42108371) (← links)
• Endothelial cell activation, oxidative stress and inflammation induced by a panel of metal-based nanomaterials (Q43482285) (← links)
• Nanosafety: towards safer design of nanomedicines (Q45367836) (← links)
• How the toxicity of nanomaterials towards different species could be simultaneously evaluated: a novel multi-nano-read-across approach. (Q48633650) (← links)
• The inflammatory response to silver and titanium dioxide nanoparticles in the central nervous system (Q46249055) (← links)
• Redox-active nanomaterials for nanomedicine applications (Q46290936) (← links)
• Perspectives from the NanoSafety Modelling Cluster on the validation criteria for (Q)SAR models used in nanotechnology (Q47639565) (← links)
• Risk Assessment and Risk Minimization in Nanomedicine: A Need for Predictive, Alternative, and 3Rs Strategies. (Q52584444) (← links)
• Implementation of Safe-by-Design for Nanomaterial Development and Safe Innovation: Why We Need a Comprehensive Approach. (Q52584670) (← links)
• 'Safe handling of nanotechnology' ten years on. (Q53646306) (← links)
• Enalos InSilicoNano platform: an online decision support tool for the design and virtual screening of nanoparticles (Q57008609) (← links)
• Addressing a bottle neck for regulation of nanomaterials: quantitative read-across (Nano-QRA) algorithm for cases when only limited data is available (Q57008772) (← links)
• Coordinating modeling and experimental research of engineered nanomaterials to improve life cycle assessment studies (Q57774733) (← links)
• Multi-omics analysis of ten carbon nanomaterials effects highlights cell type specific patterns of molecular regulation and adaptation (Q58924480) (← links)
• A high throughput imaging database of toxicological effects of nanomaterials tested on HepaRG cells (Q64072100) (← links)
• Criteria for grouping of manufactured nanomaterials to facilitate hazard and risk assessment, a systematic review of expert opinions (Q88255481) (← links)
• The Hemocompatibility of Nanoparticles: A Review of Cell-Nanoparticle Interactions and Hemostasis (Q90574278) (← links)
• Overview of the blood compatibility of nanomedicines: A trend analysis of in vitro and in vivo studies (Q90579730) (← links)
• Lignin for Nano- and Microscaled Carrier Systems: Applications, Trends, and Challenges (Q92747583) (← links)